Related Experiment Video
Updated: Oct 4, 2025

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
Published on: December 13, 2019
Evaluation of left ventricular function in children and adolescents with type 1 diabetes
Sawsan Ali Hussein1, Basil Metti Hanoudi2
1College of Medicine, Mustansiriyah University, Baghdad, Iraq.
Insights
Type 1 diabetes in children and adolescents can cause subclinical changes in heart function, even before symptoms appear. Poor blood sugar control and longer diabetes duration worsen these cardiac effects.
Area of Science:
- Pediatric Cardiology
- Endocrinology
- Cardiovascular Research
Background:
- Type 1 diabetes mellitus (T1DM) is a chronic condition affecting children and adolescents.
- Cardiac function can be impacted by diabetes, but data in pediatric populations is limited.
Purpose of the Study:
- To evaluate the effects of T1DM on cardiac systolic and diastolic functions in pediatric patients.
- To identify potential early indicators of cardiac involvement in young T1DM patients.
Main Methods:
- A case-control study involving 96 children and adolescents (5-18 years) with T1DM and healthy controls.
- Utilized clinical evaluation, laboratory tests, conventional echocardiography, and Doppler assessment.
- Analyzed data using SPSS 25.
Main Results:
- Patients with T1DM showed significantly prolonged isovolumic relaxation time and reduced early diastolic filling velocity.
- Uncontrolled diabetes and longer disease duration (≥7 years) were associated with more pronounced cardiac alterations, including changes in left atrial/ventricular dimensions and myocardial performance index.
- Subclinical myocardial dysfunction was observed in T1DM patients.
Conclusions:
- T1DM can induce subclinical myocardial functional changes in asymptomatic children and adolescents.
- Glycemic control and diabetes duration are critical factors accelerating these cardiac alterations.
Objective:
To assess the effect of type I diabetes mellitus on cardiac systolic and diastolic functions in children and adolescent patients.
Methods:
The case-control study was conducted from January 1 to December 31, 2017, at Child's Central Teaching Hospital, Baghdad, Iraq, and comprised patients with type 1 diabetes and healthy controls aged 5-18 years for 3 years or more, Clinical evaluation, laboratory investigations, conventional echocardiography and Doppler assessment were done for each individual. Data was analysed using SPSS 25.
Results:
Of the 96 subjects, 48(50%) were cases; 19(39.6%) males and 29(60.4%) females. The remaining 48(50%) were the controls; 22(45.8%) males and 26(54.2%) females. The mean age and gender distribution between the groups was not significantly different (p>0.05). Among the cases, 37(77.1%) had glycated haemoglobin ≥7.5%, and 28(58.3%) had diabetes for 7 years or more. The cases had significantly longer isovolumic relaxation time than the controls (p=0.002). The cases also had significantly lower early diastolic filling velocity (p=0.022) and early diastolic filling velocity/late diastolic filling velocity ratio (p=0.047) than the controls. Patients with uncontrolled diabetes had significant changes in left atrial and ventricular diameters, left ventricular mass and mass index, and in early diastolic filling velocity compared to those with controlled diabetes (p<0.05). Also, patients with duration of diabetes ≥7 years had higher myocardial performance index and longer isovolumic contraction time than those with shorter duration (p<0.05).
Conclusions:
Subclinical alterations in myocardial function induced by type 1 diabetes may start in asymptomatic individuals, and these changes are accelerated with poor glycaemic control and longer duration of diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy III: Hypertrophic Cardiomyopathy

